title: Contraindicated initiation of β-blocker therapy in patients hospitalized for heart failure.
authors.affiliation: Division of Cardiology, Columbia University Medical Center, New York, New York4Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut.
authors.forename: Kumar
authors.initials: K
authors.lastname: Dharmarajan
authors.forename: Frederick A
authors.initials: FA
authors.lastname: Masoudi
authors.forename: John A
authors.initials: JA
authors.lastname: Spertus
authors.forename: Shu-Xia
authors.initials: SX
authors.lastname: Li
authors.forename: Harlan M
authors.initials: HM
authors.lastname: Krumholz
mesh_terms: D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D002316:Cardiotonic Agents / Q000627:therapeutic use; D015331:Cohort Studies; D000075202:Contraindications; D004363:Drug Utilization / Q000706:statistics & numerical data*; D006333:Heart Failure / Q000188:drug therapy*; D006760:Hospitalization; D006801:Humans; D007262:Infusions, Intravenous; D007362:Intensive Care Units; D009203:Myocardial Infarction / Q000188:drug therapy; D012189:Retrospective Studies; D049994:Sodium Potassium Chloride Symporter Inhibitors / Q000627:therapeutic use; D014481:United States
chemical_list: D000319:Adrenergic beta-Antagonists; D002316:Cardiotonic Agents; D049994:Sodium Potassium Chloride Symporter Inhibitors